2 diciembre 2014
Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/yErMVVV6wJk/141201191301.htm
